1. Home
  2. SPOK vs AVIR Comparison

SPOK vs AVIR Comparison

Compare SPOK & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPOK
  • AVIR
  • Stock Information
  • Founded
  • SPOK 2004
  • AVIR N/A
  • Country
  • SPOK United States
  • AVIR United States
  • Employees
  • SPOK N/A
  • AVIR N/A
  • Industry
  • SPOK Telecommunications Equipment
  • AVIR Medicinal Chemicals and Botanical Products
  • Sector
  • SPOK Telecommunications
  • AVIR Health Care
  • Exchange
  • SPOK Nasdaq
  • AVIR Nasdaq
  • Market Cap
  • SPOK 333.4M
  • AVIR 311.4M
  • IPO Year
  • SPOK 1992
  • AVIR 2020
  • Fundamental
  • Price
  • SPOK $16.33
  • AVIR $3.87
  • Analyst Decision
  • SPOK
  • AVIR Sell
  • Analyst Count
  • SPOK 0
  • AVIR 1
  • Target Price
  • SPOK N/A
  • AVIR N/A
  • AVG Volume (30 Days)
  • SPOK 109.8K
  • AVIR 284.8K
  • Earning Date
  • SPOK 07-24-2024
  • AVIR 08-06-2024
  • Dividend Yield
  • SPOK 7.59%
  • AVIR N/A
  • EPS Growth
  • SPOK N/A
  • AVIR N/A
  • EPS
  • SPOK 0.82
  • AVIR N/A
  • Revenue
  • SPOK $140,753,000.00
  • AVIR N/A
  • Revenue This Year
  • SPOK $2.77
  • AVIR N/A
  • Revenue Next Year
  • SPOK $0.94
  • AVIR N/A
  • P/E Ratio
  • SPOK $20.13
  • AVIR N/A
  • Revenue Growth
  • SPOK 5.13
  • AVIR N/A
  • 52 Week Low
  • SPOK $10.90
  • AVIR $2.77
  • 52 Week High
  • SPOK $18.14
  • AVIR $4.60
  • Technical
  • Relative Strength Index (RSI)
  • SPOK 69.82
  • AVIR 65.48
  • Support Level
  • SPOK $14.94
  • AVIR $3.15
  • Resistance Level
  • SPOK $16.10
  • AVIR $3.34
  • Average True Range (ATR)
  • SPOK 0.34
  • AVIR 0.15
  • MACD
  • SPOK 0.18
  • AVIR 0.08
  • Stochastic Oscillator
  • SPOK 84.93
  • AVIR 91.19

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. It reports three market segments namely Healthcare, Government, and Large enterprise. The company provides paging services and software solutions in the United States and abroad. It provides services such as Value-Added Services, Advisory Services, Assessment Services and Adoption Services.

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

Share on Social Networks: